Reirradiation of recurrent glioblastoma: Results from a single-center retrospective cohort study

In this retrospective analysis, reirradiation for rGBM was feasible and safe, conferring a potential PFS benefit in selected patients. Bevacizumab emerged as a particularly promising combination partner, contributing to both RN prevention and enhanced efficacy.

Authors

Institutions

Publication Details

Journal
Clinical and Translational Radiation Oncology
Published
2025-08-08
DOI
https://doi.org/10.1016/j.ctro.2025.101029
Primary Topic
Glioma Diagnosis and Treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Reirradiation of recurrent glioblastoma: Results from a single-center retrospective cohort study

Frank A. Giordano, Fabian Kugel, Niklas Schäfer, Eleni Gkika et al.
Clinical and Translational Radiation Oncology
Glioma Diagnosis and Treatment
article

Reirradiation of recurrent glioblastoma: Results from a single-center retrospective cohort study

Frank A. Giordano, Fabian Kugel, Niklas Schäfer, Eleni Gkika, Cas Stefaan Dejonckheere, Hartmut Vatter, Davide Scafa, Julian Philipp Layer, Cathrina Duffy, Matthias Schneider, Anca-Ligia Grosu, Gustavo R. Sarria, Anna‐Laura Potthoff, Younèss Nour, Ulrich Herrlinger, Thomas Zeyen, Alexander Radbruch, Christina Leitzen, Lea L Friker, Yannik C. Layer, Barbara Daria Wichtmann
article en

Abstract

In this retrospective analysis, reirradiation for rGBM was feasible and safe, conferring a potential PFS benefit in selected patients. Bevacizumab emerged as a particularly promising combination partner, contributing to both RN prevention and enhanced efficacy.

Clinical and Translational Radiation OncologyVol. 55
University of Freiburg (DE), University of Mannheim (DE), Heidelberg University (DE), University Hospital Bonn (DE), University Medical Center Freiburg (DE), University Hospital Heidelberg (DE), Integrated Oncology (United States) (US), University Medical Centre Mannheim (DE)
Zero hunger
Openalex Percentile: Top 72%
Glioma Diagnosis and Treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.